The biological impact of BRCA1 and BRCA2 mutations are histology-dependent, in that they are indispensable founding events in some tumors (e.g., breast, ovarian, prostate and pancreatic cancer) and inert in others [35]. Here, BRCA2 is linked to familial pancreatic carcinoma.